ES459382A1 - Procedimiento para preparar acidos quinolonpropionicos. - Google Patents
Procedimiento para preparar acidos quinolonpropionicos.Info
- Publication number
- ES459382A1 ES459382A1 ES459382A ES459382A ES459382A1 ES 459382 A1 ES459382 A1 ES 459382A1 ES 459382 A ES459382 A ES 459382A ES 459382 A ES459382 A ES 459382A ES 459382 A1 ES459382 A1 ES 459382A1
- Authority
- ES
- Spain
- Prior art keywords
- quinolone derivatives
- methyl radical
- formula
- radical
- quinolonpropionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB11644/75A GB1502312A (en) | 1975-03-20 | 1975-03-20 | Quinolone derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES459382A1 true ES459382A1 (es) | 1978-11-16 |
Family
ID=9990065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES459382A Expired ES459382A1 (es) | 1975-03-20 | 1977-06-01 | Procedimiento para preparar acidos quinolonpropionicos. |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE839839A (fr) |
| ES (1) | ES459382A1 (fr) |
| GB (1) | GB1502312A (fr) |
| ZA (1) | ZA761097B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47592B1 (en) | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| US5225402A (en) * | 1989-02-10 | 1993-07-06 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途 |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| MX2010002537A (es) | 2007-09-14 | 2010-08-10 | Ortho Mcneil Janssen Pharm | 4-fenil-1h-piridin-2-onas 1,3-disubstituidas. |
| PT2203439E (pt) | 2007-09-14 | 2011-02-11 | Ortho Mcneil Janssen Pharm | 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridinil-2'- onas 1',3'-dissubstituídas |
| ES2365966T3 (es) | 2007-09-14 | 2011-10-14 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-disustituidas. |
| CN101861316B (zh) | 2007-11-14 | 2013-08-21 | 奥梅-杨森制药有限公司 | 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| CA2735764C (fr) | 2008-09-02 | 2016-06-14 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Derives de 3-azabicyclo[3.1.0]hexyle comme modulateurs des recepteurs metabotropiques du glutamate |
| CA2738849C (fr) | 2008-10-16 | 2016-06-28 | Addex Pharma S.A. | Derives d'indole et de benzomorpholine en tant que modulateurs des recepteurs metabotropiques du glutamate |
| MX2011005242A (es) | 2008-11-28 | 2011-09-06 | Ortho Mcneil Janssen Pharm | Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos. |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| MX2011011964A (es) | 2009-05-12 | 2012-02-23 | Janssen Pharmaceuticals Inc | Derivados de 1,2,3-triazolo[4,3-a]piridina y su uso para el tratamiento o prevencion de trastornos neurologicos y psiquiatricos. |
| AR076859A1 (es) | 2009-05-12 | 2011-07-13 | Ortho Mcneil Janssen Pharm | Derivados de 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2 , composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos. |
| CN103298809B (zh) | 2010-11-08 | 2016-08-31 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| PL2649069T3 (pl) | 2010-11-08 | 2016-01-29 | Janssen Pharmaceuticals Inc | Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2 |
| CA2814998C (fr) | 2010-11-08 | 2019-10-29 | Janssen Pharmaceuticals, Inc. | Derives de 1,2,4-triazolo[4,3-a]pyridine et leur utilisation en tant que modulateurs allosteriques positifs des recepteurs mglur2 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| PT3096790T (pt) | 2014-01-21 | 2019-10-15 | Janssen Pharmaceutica Nv | Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso |
| AU2015208233B2 (en) | 2014-01-21 | 2019-08-29 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
-
1975
- 1975-03-20 GB GB11644/75A patent/GB1502312A/en not_active Expired
-
1976
- 1976-02-24 ZA ZA761097A patent/ZA761097B/xx unknown
- 1976-08-19 BE BE165404A patent/BE839839A/fr unknown
-
1977
- 1977-06-01 ES ES459382A patent/ES459382A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE839839A (fr) | 1976-09-20 |
| ZA761097B (en) | 1977-02-23 |
| GB1502312A (en) | 1978-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES459382A1 (es) | Procedimiento para preparar acidos quinolonpropionicos. | |
| ES457993A1 (es) | Un procedimiento para la preparacion de una isotiazolopiri- dina. | |
| ES459383A1 (es) | Procedimiento para preparar acidos quinolonpropionicos. | |
| JPS52264A (en) | Process for preparing novel isoxazole derivatives | |
| ES462849A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina. | |
| JPS5265267A (en) | Synthesis of spiro compounds | |
| ES456912A1 (es) | Un procedimiento para la preparacion de nuevos derivados de bencimidazol-2-carbamato antihelminticamente activos. | |
| ES462784A1 (es) | Procedimiento para la produccion de cromanonas. | |
| ES479234A1 (es) | Procedimiento para la obtencion de derivados de antraquinona. | |
| ES462844A1 (es) | Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos. | |
| ES420766A1 (es) | Un procedimiento para la produccion de nuevos derivados de alfa-pirona. | |
| ES279898A1 (es) | Procedimiento para la obtención de (4-alquilo-piperacina)-sulfonamidas | |
| ES472572A1 (es) | Un procedimiento para la preparacion de derivados de morfi- nano 3-fenoxi-n-sustituidos levogiros | |
| ES464851A1 (es) | Procedimiento para la preparacion de derivados de acidos 3- carboxifenilaceticos. | |
| ES458389A1 (es) | Procedimiento para preparar derivados de prostaglandina. | |
| ES325448A1 (es) | Procedimiento para producir 4-amino-5-halo-2-derivados de benzamida. | |
| ES459400A1 (es) | Un procedimiento para la produccion de nuevos compuestos de 6,11-dihidrodibenzo (b.e.) tiepin-11-ona. | |
| JPS5283362A (en) | Synthesis of isoindoline derivative pigment | |
| ES462656A1 (es) | Un procedimiento para la preparacion de derivados de cefa- losporina. | |
| JPS5412384A (en) | Carbostyril derivative | |
| ES472164A1 (es) | Ÿprocedimiento de obtencion de 5,5-dioxido de 7-amino-4-me- til-3h-imidazo (2,3-c) (1,2,6) tiadiazinaÿ | |
| ES450472A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 3-benzoil-pirazol. | |
| ES450627A1 (es) | Un procedimiento para la preparacion de nuevos derivados de arilcarboxamida. | |
| ES479233A1 (es) | Procedimiento para la obtencion de derivados de antraquinona. | |
| ES456093A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1-tiazolinil bencimidazoles 5(6)-sustituidos. |